Latest News and Press Releases

Marking the First Major Consolidation in Pharmaceutical Grade Medical Cannabis Market Acquisition is Expected to be Accretive Strengthen InterCure’s Position as the Largest Cannabis Company Outside...

Estimated revenue reaches over CAD$31 million (a record NIS 77 million) Anticipates continued increases in adjusted operating profit and EBITDA Revenue growth expected to continue...

NEW YORK and TORONTO and HERZLIYA, Israel, Dec. 02, 2021 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) ("InterCure" or the “Company”) today announced its...

NEW YORK and TORONTO and HERZLIYA, Israel, Nov. 29, 2021 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) ("InterCure" or the “Company”) today announced...

Seventh consecutive quarter of high double-digit, sequential revenue growth Annualized revenues run rate of $100 million Adjusted EBITDA1 run rate of $23 million $85 million in cash ...

With addition of four new pharmacies, InterCure’s dedicated chain GIVOL now has 20 locations across Israel NEW YORK and TORONTO and HERZLIYA, Israel, Nov. 15, 2021 (GLOBE NEWSWIRE) -- InterCure...

NEW YORK and TORONTO and HERZLIYA, Israel, Nov. 11, 2021 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the “Company”) today announced that...

Achieved a number of firsts and records including: Seventh consecutive quarter of double-digit revenue growth Seventh consecutive quarter of high digit accelerated profitable growth Record...

NEW YORK and TORONTO and HERZLIYA, Israel, Oct. 13, 2021 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the “Company”) today announced that...

NEW YORK, TORONTO and HERZLIYA, Israel, Oct. 12, 2021 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) ("InterCure" or the “Company”) today announced that...